SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Martin Luther King Jr.

PatientMartin Luther King
Date of birth1990-01-15
IdentifiersMRN HR-ML001-SYN; SSN (made up) 000-01-4058
Document date2026-07-14
AuthorCornelius Ashby-Nwankwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Fourteen-week review: mood, sleep, varenicline, blood pressure and the work plan. [S]

History of Present Illness

Dr. King returns six weeks after his eight-week review, just back from a two-week break with his family, the first he has taken in years. He had a video review with Dr. Lindqvist-Bankole last month, who agreed with the plan. His mood is clearly better; he enjoys reading and preaching again and sleeps about six and a half hours. He had one lapse in June, smoking three cigarettes late one night after a threatening call, and has not smoked since. He finishes twelve weeks of varenicline in about four weeks. Home readings over the past week averaged 132/84. He walks most mornings when he is at home and has cut back on fried food. He has no thoughts of harming himself. [S]

ElementDetail
BreakTwo weeks away; first in years
MoodBetter; PHQ-9 8
SmokingOne lapse of three cigarettes in June; smoke-free since
Home blood pressureAverage 132/84

Review of Systems

SystemResultFinding
ConstitutionalNegativeRested; more energy
RespiratoryNegativeNo cough
CardiovascularNegativeNo chest pain or palpitations
PsychiatricPositiveMood mostly good; still watchful in crowds; no suicidal ideation

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Varenicline 0.5 mg tablet, one by mouth once daily for 3 days, then twice daily for 4 daysonce daily for 3 days, then twice daily for 4 days, after foodOral route2026-05-12 to 2026-05-19completedS
Varenicline 1 mg tablet, one by mouth twice daily after foodtwice daily after foodOral route2026-05-19activeS
Sertraline 25 mg tablet, one by mouth each morning for one weekonce daily in the morningOral route2026-04-20 to 2026-04-27completedS
Sertraline 50 mg tablet, one by mouth each morningonce daily in the morningOral route2026-04-27activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-07-14Body height170cmS
2026-07-14Body weight84kgS
2026-07-14Body mass index (BMI) [Ratio]29.1kg/m2S
2026-07-14Systolic blood pressure130mm[Hg]S
2026-07-14Diastolic blood pressure84mm[Hg]S
2026-07-14Heart rate72/minS
2026-07-14Respiratory rate14/minS
2026-07-14Body temperature36.6CelS
2026-07-14Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-14Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
2026-07-14Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]5{score}S
2026-07-14PC-PTSD-5 score [PC-PTSD-5]1{score}S

Physical Exam

Vital signs recorded on 2026-07-14; see the Vital Signs section. [S]

SystemFinding
GeneralRested; blood pressure 130/84, pulse 72; weight 84.0 kg, BMI 29.1
CardiovascularRegular rhythm; no murmur
PsychiatricEuthymic, warm, reactive affect; no suicidal ideation

Problems

ProblemClinical statusVerificationCodeProvenance
Exhaustion, broken sleep and low mood for about two months, under sustained threats and a punishing schedule, after an admission for exhaustion and a respiratory infection six months ago; cause not established at intake: a depressive disorder, an adjustment disorder, PTSD, an insomnia disorder, thyroid disease and anemia to be assessed; psychiatry consultation requestedresolvedconfirmed R53.83S — Synthetic presenting problem anchored to his documented admission for exhaustion and the threats against him; superseded by the diagnoses at the second visit.
Major depressive disorder, single episode, moderate (DSM-5-TR), arising under chronic threat, surveillance and overwork; no suicidal ideation; PTSD not present on screening and interviewactiveconfirmed F32.1S — Synthetic modern diagnosis made at the psychiatry consultation, linked to his documented exhaustion and threats and to biographers' accounts of depression (R); not a claim that he was so diagnosed.
Insomnia disorder (DSM-5-TR), comorbid with depression: trouble falling and staying asleep at least four nights a week for over three months, with short sleep from late-night work and travelactiveconfirmed G47.00S — Synthetic modern diagnosis made at the psychiatry consultation.
Nicotine dependence, cigarettes: about a pack a day since his twenties, smoked out of public viewactiveconfirmed F17.210S — Synthetic modern problem anchored to the documented account of his heavy, hidden smoking.
Elevated blood pressure readings in the clinic (138/88 mmHg) without a diagnosis of hypertension; home monitoring to confirmresolvedconfirmed R03.0S — Synthetic presenting finding; superseded by the diagnosis at the six-week visit.
Healed stab wound of the left chest, repaired by thoracotomy seven years ago; occasional aching along the scar with coughing and in cold weather, without exertional or ischemic featuresactiveconfirmed Z87.828S — Synthetic modern problem anchored to his documented stabbing and chest surgery in 1958.
Stage 1 hypertension (2017 ACC/AHA), confirmed by home readings averaging 136/86 mmHg; no end-organ damage (normal ECG, urine albumin, kidney function and fundi); low estimated 10-year risk; lifestyle treatmentactiveconfirmed I10S — Synthetic modern diagnosis made at the eight-week visit; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPHQ-9At least monthly during acute treatment; every 2 to 4 weeks in continuationCompleted today8, a 53 percent fall from 17
SurveyGAD-7Every 4 to 8 weeks during treatmentCompleted today5
SurveyPTSD screen (PC-PTSD-5)Repeat at about three months and if trauma symptoms emergeCompleted today1: on guard only; no PTSD
SurveySuicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9)Every visitCompleted todayNo suicidal ideation; PHQ-9 item 9 scored 0. Safety plan reviewed
ReferralPsychiatry follow-upAt about eight to twelve weeksCompleted todayVideo review with Dr. Lindqvist-Bankole last month; plan unchanged
Medication safetyAdherence and adverse-effect reviewEvery visitCompleted todayNo missed sertraline doses; nausea on varenicline has settled
Self-managementSmoking status after the quit dateEvery visitCompleted todayOne lapse in June; smoke-free since
SurveyInsomnia Severity Index and sleep diaryEvery visit during CBT for insomniaCompleted todayInsomnia Severity Index 10; about six and a half hours a night (score in the notes; no LOINC code used)
ExaminationHome blood pressure readingsA week before each visit while treatment is adjustedCompleted todaySeven-day average 132/84
ExaminationOffice blood pressure, weight and BMIEvery visitCompleted today130/84 mmHg; weight 84.0 kg
Self-managementSustainable work plan: a day off each week, two speeches a day at most, sleep window keptEvery visitCompleted todayDay off kept most weeks; two-week break taken

Goal progress:

Guideline basis: Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders, hypertension and hyperlipidemia monographs (2026); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES) (2016); 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017)

Follow-up: Review in nine weeks with repeat lipids. Next scheduled visit 2026-09-15: twenty-three-week review: remission, smoking, blood pressure and lipids. [S]